Final 5-year results of Z-FAST trial-Reference-Cited by-同舟云学术

Final 5-year results of Z-FAST trial

Published:2011-10-10 Issue:5 Volume:118 Page:1192-1201
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Brufsky Adam M.,Harker W. Graydon,Beck J. Thaddeus,Bosserman Linda,Vogel Charles,Seidler Christopher,Jin Lixian,Warsi Ghulam,Argonza-Aviles Eliza,Hohneker John,Ericson Solveig G.,Perez Edith A.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference35 articles.

1. Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230;Eastell;J Clin Oncol,2008

2. Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer;Brufsky;J Clin Oncol,2007

3. Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole;Brufsky;Oncologist,2008

4. National Comprehensive Cancer Network www.nccn.org

5. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98;Coates;J Clin Oncol,2007

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer treatment-induced bone loss;The Korean Journal of Internal Medicine;2024-09-01

2. Bone-modifying agents for reducing bone loss in women with early and locally advanced breast cancer: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-07-09

3. Management of cancer treatment–induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey;Tumori Journal;2024-03-10

4. Assessment of bone turnover markers and DXA parameters to predict bone metastasis progression during zoledronate treatment: a single-center experience;Clinical and Experimental Medicine;2024-01-19

5. Bisphosphonates as Radiopharmaceuticals: Spotlight on the Development and Clinical Use of DOTAZOL in Diagnostics and Palliative Radionuclide Therapy;International Journal of Molecular Sciences;2023-12-29